A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Clinical trial NCT04656184 · RECRUITING
Trial details
- NCT number
- NCT04656184
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2027-03-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.